전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
biopharmaceutical characterisation and bioavailability/ bioequivalence of herbal drugs/preparations position paper on the risk associated with the use of herbal products containing estragole position paper on the risk associated with the use of herbal products containing methyleugenol position paper on the risk associated with the use of herbal
Τίτλος εγγράφου note for guidance on non- clinical testing of herbal drug preparations with long- term marketing experience - guidance to facilitate mutual recognition and use of bibliographic data concept paper for a note for guidance on the investigation of biopharmaceutical characterisation and bioavailability/ bioequivalence of herbal drugs/ preparations position paper on the risk associated with the use of herbal products containing estragole position paper on the risk associated with the use of herbal products containing methyleugenol position paper on the risk associated with the use of herbal products containing α - and β- asarone position paper on the use of sassafras albidum as active substance or ingredient in herbal medicinal products
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
these maximum levels do not apply to three substances: estragole, safrole and methyleugenol, when present in compound foods to which no flavourings have been added and only food ingredients with flavouring properties in the form of herbs and/or spices have been added.
Αυτά τα ανώτατα όρια δεν ισχύουν για τρεις ουσίες: εστραγκόλη, σαφρόλη και μεθυλευγενόλη, όταν απαντώνται σε σύνθετα τρόφιμα στα οποία δεν έχει προστεθεί καμία αρωματική ουσία, αλλά υπάρχουν μόνο συστατικά τροφίμων με αρωματικές ιδιότητες υπό μορφή βοτάνων ή/και καρυκευμάτων.
마지막 업데이트: 2012-02-28
사용 빈도: 2
품질: